Rather than unpacking the actual causes of Lykos Therapeutics' disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health. The post Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia appeared first on Psymposia.
